Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2008-02-19
2009-12-22
Aeder, Sean E (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
07635753
ABSTRACT:
Methods for identifying a human subject as a candidate for further prostate cancer or melanoma examination are disclosed. Also disclosed are methods for determining whether an immune therapy has elicited a tumor-specific immune response in a prostate cancer or melanoma patient. Further disclosed are kits that can be used to practice the above methods. Methods for identifying candidate compounds for further testing as preventive or therapeutic agents for melanoma are also disclosed.
REFERENCES:
patent: WO 00/00824 (2000-01-01), None
Dunphy et al (Journal of Clinical Immunology, Sep. 2004, 24(5): 492-502).
Bradford T, et al., “Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer,” Urol. Oncol. 24:237-242 (2006).
Brinkmann U, et al., “Novel genes in the PAGE and GAGE family of tumor antigens found by homology walking in the dbEST database,” Cancer Res. 59:1445-1448 (1999).
Chen Y, et al., “A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening,” Proc. Natl. Acad. Sci. USA 94:1914-1918 (1997).
Chen Y, et al., “Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library,” Proc Natl Acad Sci USA 95:6919-6923 (1998).
Chen M, et al., Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens, J. Biol. Chem. 273:17618-17625 (1998).
Crew A, et al., “Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma,” Embo. J. 14:2333-2340 (1995).
De Plaen E, et al., “Structure, chromosomal localization, and expression of 12 genes of the MAGE family,” Immunogenetics 40:360-369 (1994).
Dong X, et al., “Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients,” Br. J. Cancer 89:291-297 (2003).
Dunphy E, et al., “Identification of antigen-specific IgG in sera from patients with chronic prostatitis,” J. Clin Immunol. 24:492-502 (2004).
Gure A, et al., “SSX: a multigene family with several members transcribed in normal testis and human cancer,” Int. J. Cancer 72:965-971 (1997).
Hoeppner L, et al., “Humoral immune responses to testis antigens in sera from patients with prostate cancer,” Cancer Immun. 6:1-7 (2006).
Kasahara M, et al., “A testis-specific gene Tpx-1 maps between Pgk-2 and Mep-1 on mouse chromosome 17,” Immunogenetics 29:61-63 (1989).
Lee S, et al., “Immunomic analysis of human sarcoma,” Proc Natl Acad Sci USA 100:2651-2656 (2003).
Lim S, et al., “Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma,” Blood 97:1508-1510 (2001).
Loriot A, et al., “Five new human cancer-germline genes identified among 12 genes expressed in spermatogonia,” Int. J. Cancer 105:371-376 (2003).
Lurquin C, et al., “Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins,” Genomics 46:397-408 (1997).
McNeel D, et al., “Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer,” J. Urol. 164:1825-1829 (2000).
Mooney C, et al., “Identification of autoantibodies elicited in a patient with prostate cancer presenting as dermatomyositis,” Inter. J. Urology 13:211-217 (2006).
Sasaki M, et al., “MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma,” Cancer Res. 61:4809-4814 (2001).
Scanlan M, et al., “Identification of cancer/testis genes by database mining and mRNA expression analysis,” Int. J. Cancer 98:485-492 (2002).
Van der Bruggen P, et al., “A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma,” Science 254:1643-1647 (1991).
Van den Eynde B, et al., “A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma,” J. Exp. Med. 182:689-698 (1995).
Wang X, et al., “Autoantibody signatures in prostate cancer,” N. Engl. J. Med. 353:1224-1235 (2005).
Yuan L, et al., “Isolation of a novel gene, TSP50, by a hypomethylated DNA fragment in human breast cancer,” Cancer Res. 59:3215-3221 (1999).
Zendman A, et al., “CTp11, a novel member of the family of human cancer/testis antigens,” Cancer Res. 59:6223-6229 (1999).
Scanlan, Matthew J. et al., “The Cancer/Testis Genes: Review, Standardization, and Commentary,” Cancer Immunity 4:1 (2004).
Wagner, Claudia et al., “Identification of an HLA-A*02 Restricted Immunogenic Peptide Derived from the Cancer Testis Antigen HOM-MEL-40/SSx2,” Cancer Immunity 3:18 (2003).
Dubovsky Jason A.
Dunphy Edward J.
Hoeppner Luke H.
McNeel Douglas G.
Aeder Sean E
Quarles & Brady LLP
Wisconsin Alumni Research Foundation
LandOfFree
Prostate cancer and melanoma antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostate cancer and melanoma antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate cancer and melanoma antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4148340